Switch to:
More From Other Websites
Abbvie expects to bring endometriosis drug to FDA in 2017 Feb 10 2016
AbbVie Announces Positive Top-Line Results From Second Phase 3 Study Investigating Elagolix in... Feb 10 2016
Neurocrine Biosciences Announces Conference Call and Webcast to Report Fourth Quarter and Year-End... Feb 08 2016
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 05 2016
Neurocrine Biosciences to Present at the Leerink Partners 5th Annual Global Healthcare Conference Feb 03 2016
Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in... Feb 02 2016
Stock Watchout on Drugs - Generic -- Mylan, Neurocrine Biosciences, Horizon Pharma, and Zoetis Feb 02 2016
AbbVie Initiates Enrollment in Phase 3 Clinical Program for Elagolix in Patients with Uterine... Jan 28 2016
Four Stocks Driving Thursday’s Market Gains: How Did They Do It? Jan 14 2016
Neurocrine Biosciences, Inc. – Value Analysis (NASDAQ:NBIX) : January 5, 2016 Jan 05 2016
Neurocrine Biosciences, Inc. breached its 50 day moving average in a Bearish Manner : January 5,... Jan 05 2016
Neurocrine Biosciences to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 04 2016
Neurocrine Biosciences to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 04 2016
4 stocks to watch Dec 31 2015
5 Top Performing Stocks of the Top ETF of 2015 Dec 28 2015
Niche Hedge Funds lead the pack in 2015 Dec 22 2015
Neurocrine Biosciences, Inc. breached its 50 day moving average in a Bearish Manner : December 22,... Dec 22 2015
NBIX: Successful Phase 1b Trial Results for NBI-98854 in Tourette Syndrome Caps a Banner Year for... Dec 18 2015
Neurocrine Announces Successful Completion of Phase Ib T-Force Study of VMAT2 Inhibitor NBI-98854 in... Dec 16 2015
NEUROCRINE BIOSCIENCES INC Financials Dec 08 2015
Icahn School Of Medicine At Mount Sanai Files Complaint Against Neurocrine Sciences For Breach Of... Dec 02 2015
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Other Events Dec 02 2015
Neurocrine Biosciences to Present at the 27th Annual Piper Jaffray Healthcare Conference Nov 25 2015
Neurocrine Biosciences to Present at the Jefferies Autumn 2015 Global Healthcare Conference Nov 11 2015
Neurocrine Biosciences Announces Expansion of its Clinical Pipeline Nov 04 2015
Neurocrine reports 3Q loss Oct 29 2015
Neurocrine Biosciences Reports Third Quarter 2015 Results Oct 29 2015
Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2015 Results Oct 22 2015
Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor NBI-98854 in Adults... Oct 20 2015
Neurocrine Announces Positive Results from Phase III Kinect 3 Study of NBI-98854 in Tardive... Oct 08 2015
Neurocrine Biosciences Announces the Appointment of George J. Morrow to its Board of Directors Sep 30 2015
AbbVie Announces Plans to Proceed to Phase 3 Evaluation of Elagolix in Patients with Uterine... Sep 16 2015
Neurocrine Biosciences to Present at the Morgan Stanley Global Healthcare Conference Sep 10 2015
Neurocrine Biosciences Announces the Appointment of Dr. Alfred W. Sandrock to its Board of Directors Sep 03 2015
Neurocrine Biosciences to Present at the Baird 2015 Healthcare Conference Sep 02 2015
Neurocrine Announces Completion of Enrollment into Kinect 3 Tardive Dyskinesia Study Aug 13 2015
Neurocrine reports 2Q loss Jul 29 2015
Neurocrine Biosciences Reports Second Quarter 2015 Results Jul 29 2015
Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2015 Results Jul 22 2015
Neurocrine Biosciences Provides Update on NBI-77860 Program for Congenital Adrenal Hyperplasia Jun 08 2015
Neurocrine Biosciences, Inc. Announces Appointment of Eric Benevich as Chief Commercial Officer Jun 02 2015
Neurocrine Biosciences to Present at the Jefferies 2015 Healthcare Conference May 27 2015
Neurocrine Biosciences to Host Analyst and Investor Day in New York City on May 21, 2015 May 21 2015
Neurocrine reports 1Q loss Apr 30 2015
Neurocrine reports 4Q loss Feb 09 2015
Neurocrine meets 3Q profit forecasts Nov 03 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK